pyridoxamine has been researched along with allopurinol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cazenave, M; Gauthier, M; Gueutin, V; Izzedine, H | 1 |
| Fried, LF; Pena-Polanco, JE | 1 |
2 review(s) available for pyridoxamine and allopurinol
| Article | Year |
|---|---|
[Diabetic nephropathy: emerging treatments].
Topics: Adrenocorticotropic Hormone; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antifibrinolytic Agents; Antineoplastic Agents, Hormonal; Antioxidants; Bone Density Conservation Agents; Diabetic Nephropathies; Doxycycline; Enzyme Inhibitors; Ergocalciferols; Hormones; Humans; Indoles; Maleimides; Octreotide; Pentoxifylline; Pyridones; Pyridoxamine; Silymarin; Vitamin B Complex | 2014 |
Established and Emerging Strategies in the Treatment of Chronic Kidney Disease.
Topics: Allopurinol; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bicarbonates; Diabetes Mellitus; Diabetic Nephropathies; Disease Progression; Endothelin Receptor Antagonists; Ergocalciferols; Free Radical Scavengers; Glycated Hemoglobin; Gout Suppressants; Humans; Hypertension; Hyperuricemia; Hypoglycemic Agents; Kidney Failure, Chronic; Mineralocorticoid Receptor Antagonists; Pentoxifylline; Pyridoxamine; Renal Insufficiency, Chronic; Vitamin B Complex | 2016 |